Literature DB >> 10579597

Mood and the menopausal transition.

L Dennerstein1, P Lehert, H Burger, E Dudley.   

Abstract

This study determined which variables affect women's mood state during the menopausal transition by using six prospective annual assessments of a community-based sample of 354 Australian mid-aged women. Repeated measures multivariate analysis of covariance found that negative mood scores decreased significantly over time and were not related to natural menopausal transition, follicle-stimulating hormone, estradiol, inhibin, age, or education. The magnitude of negative mood was significantly predicted by baseline reporting of premenstrual complaints, negative attitudes to ageing and menopause, and parity of one. During follow-up, the magnitude of negative mood was significantly adversely affected by: prior experience of negative mood, experience of bothersome symptoms, poor self-rated health, negative feelings for partner, no partner, current smoking, low exercise, daily hassles, and high stress. Negative mood was reduced by decreasing symptoms, improving health, positive feelings for partner, gaining a partner, and reducing stress. The menopausal transition had an indirect effect in amplifying the effect of reducing paid work, poor health, and daily hassles.

Entities:  

Mesh:

Year:  1999        PMID: 10579597     DOI: 10.1097/00005053-199911000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  23 in total

Review 1.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Mono(2-ethylhexyl) phthalate accelerates early folliculogenesis and inhibits steroidogenesis in cultured mouse whole ovaries and antral follicles.

Authors:  Patrick R Hannon; Katherine E Brannick; Wei Wang; Jodi A Flaws
Journal:  Biol Reprod       Date:  2015-03-25       Impact factor: 4.285

3.  Co-treatment of mouse antral follicles with 17β-estradiol interferes with mono-2-ethylhexyl phthalate (MEHP)-induced atresia and altered apoptosis gene expression.

Authors:  Zelieann R Craig; Jeffrey Singh; Rupesh K Gupta; Jodi A Flaws
Journal:  Reprod Toxicol       Date:  2014-01-09       Impact factor: 3.143

4.  Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice.

Authors:  Nivedita Sen; Xiaosong Liu; Zelieann R Craig
Journal:  Reprod Toxicol       Date:  2015-03-09       Impact factor: 3.143

5.  Risk assessment for psychological disorders in postmenopausal women.

Authors:  Anuradha Tamaria; Rekha Bharti; Manjula Sharma; Rupali Dewan; Garima Kapoor; Abha Aggarwal; Achla Batra; Aruna Batra
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 6.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  Di-n-butyl phthalate disrupts the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles.

Authors:  Zelieann R Craig; Patrick R Hannon; Wei Wang; Ayelet Ziv-Gal; Jodi A Flaws
Journal:  Biol Reprod       Date:  2013-01-31       Impact factor: 4.285

Review 8.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

9.  Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.

Authors:  Shreya Patel; Jackye Peretz; Yuan-Xiang Pan; William G Helferich; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-12       Impact factor: 4.219

10.  Does menopausal transition really influence mental health? Findings from the prospective long-term Zurich study.

Authors:  Wulf Rössler; Vladeta Ajdacic-Gross; Anita Riecher-Rössler; Jules Angst; Michael P Hengartner
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.